MedTrace Logo

The Effect of Oral Hyaluronic Acid (UltraHA®) on the Knee Function

NCT05683327 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 66

Last updated 2023-07-20

No results posted yet for this study

Summary

This clinical trial aims to clarify the effect of UltraHA® on knee joint conditions.

Conditions

  • Healthy Japanese Subjects

Interventions

DIETARY_SUPPLEMENT

UltraHA® 75 mg/capsule

Take 2 capsules per day at any time.

DIETARY_SUPPLEMENT

UltraHA® 40 mg/capsule

Take 2 capsules per day at any time.

DIETARY_SUPPLEMENT

Placebo

Take 2 capsules per day at any time.

Sponsors & Collaborators

  • BLOOMAGE BIOTECHNOLOGY CORPORATION LIMITED

    collaborator UNKNOWN

  • Orthomedico Inc.

    lead OTHER

Principal Investigators

  • Tsuyoshi Takara, MD · Medical Corporation Seishinkai, Takara Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2023-01-06
Primary Completion
2023-06-24
Completion
2023-06-24

Countries

  • Japan

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05683327 on ClinicalTrials.gov